Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Current Deferred Revenue: 2009-2024

Historic Current Deferred Revenue for Lifecore Biomedical (LFCR) over the last 15 years, with Nov 2024 value amounting to $9.0 million.

  • Lifecore Biomedical's Current Deferred Revenue rose 4.73% to $9.0 million in Q4 2024 from the same period last year, while for Nov 2024 it was $9.0 million, marking a year-over-year increase of 4.73%. This contributed to the annual value of $10.6 million for FY2024, which is 51.17% up from last year.
  • According to the latest figures from Q4 2024, Lifecore Biomedical's Current Deferred Revenue is $9.0 million, which was down 2.64% from $9.3 million recorded in Q3 2024.
  • Lifecore Biomedical's 5-year Current Deferred Revenue high stood at $10.6 million for Q2 2024, and its period low was $287,000 during Q2 2021.
  • Moreover, its 3-year median value for Current Deferred Revenue was $5.2 million (2023), whereas its average is $5.4 million.
  • Per our database at Business Quant, Lifecore Biomedical's Current Deferred Revenue plummeted by 51.94% in 2020 and then surged by 1,145.33% in 2023.
  • Lifecore Biomedical's Current Deferred Revenue (Quarterly) stood at $297,000 in 2020, then soared by 225.59% to $967,000 in 2021, then fell by 24.41% to $731,000 in 2022, then surged by 1,076.47% to $8.6 million in 2023, then grew by 4.73% to $9.0 million in 2024.
  • Its Current Deferred Revenue was $9.0 million in Q4 2024, compared to $9.3 million in Q3 2024 and $10.6 million in Q2 2024.